CRISPR-Cas in Agriculture
Posted by btwatson on January 26, 2018 5:58 am
Tags:
Categories:
Crispr
If everything goes according to plan, DuPont Pioneer will roll out the first CRISPR seeds in 2020. To avoid the controversy that has dogged GMOs and Big Agriculture for two decades, DuPont Pioneer is already working on its strategy to educate the public about the gene-editing technology.
Crispr News
-
Crispr: My Long Term 'Wait And Watch' Punt On The Future Of Gene Editing (NASDAQ:CRSP) - Seeking AlphaAugust 8, 2022
-
New portable diagnostic detects SARS-CoV-2 RNA and antibodies at the same time - EurekAlertAugust 8, 2022
-
CRISPR Therapeutics GAAP EPS of -$2.40 misses by $0.19, revenue of $0.16M misses by $2.04M (NASDAQ:CRSP) - Seeking AlphaAugust 8, 2022
-
CRISPR THERAPEUTICS AG Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.comAugust 8, 2022
-
Pfizer bets $5.4bn against gene therapies in sickle cell - Evaluate PharmaAugust 8, 2022
-
Epigenic Therapeutics raises $20M for gene editing technology - Labiotech.euAugust 8, 2022
-
Episode 11 - CRISPR with Dr Jakob Haaber & Dr Richard Fox - Drug Target ReviewAugust 8, 2022
-
CRISPR and Cas Genes Market Size, Scope, Growth Opportunities, Trends by Manufacturers And Forecast to 2029 – Shanghaiist - ShanghaiistAugust 8, 2022
-
Vertex: Q2 2022 Earnings Steady - But Expect Volatility Soon (NASDAQ:VRTX) - Seeking AlphaAugust 5, 2022
-
New Products Posted to GenomeWeb: Thermo Fisher, Seer, Novacyt, Artisan Bio, More - GenomeWebAugust 5, 2022
-
'TnpB protein, a new tool in CRISPR-Cas gene editing' - KBRAugust 5, 2022
-
Cancers and heart disease could be diagnosed more easily with new rapid test - Imperial College LondonAugust 4, 2022
-
Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress - Yahoo FinanceAugust 4, 2022
-
Global Genome Editing Technologies market is projected to grow at a CAGR of 15.96% by 2032: Visiongain Re - BenzingaAugust 4, 2022
-
Podcast: CRISPR can cause cancer? Vitamin B6 may fight depression; COVID 'groupthink' - Genetic Literacy ProjectAugust 4, 2022
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.